Jaguar Land Rover (JLR) clocked a 29% surge in the global retail sales of its hybrid vehicles during the first half of the financial year 2025. This increase is indicative of the growing demand for plug-in hybrid models.

What Happened: The company attributed this sales boost to customers increasingly adopting the technology as a transition towards battery electric vehicles (BEV).

“Demand is growing for our plug‑in electric hybrid models as customers become more accustomed to electrification,” JLR said in the press release.

The Range Rover brand saw a 47% rise in global plug-in hybrid electric vehicle (PHEV) retail sales in the first half of this financial year. The Defender model also posted a 23% increase in global retail sales compared to the previous financial year.

The luxury car maker added that it currently has over 48,000 clients on the waiting list for the Range Rover Electric.

See Also: Adani Power Jumps 1% After Ratings Agency Upgrades Outlook, Co Wins Order

JLR also emphasised its commitment to offering a range of fuel options to meet the energy transition dynamics of each market. The company plans to offer a pure electric variant of each nameplate by 2030, aiming to achieve carbon net zero by 2039.

This surge in hybrid vehicle sales comes at a time when Tata Motors, the parent company of JLR, has been grappling with a slump in its share price. The slump has been attributed to the company’s decline in sales in the past few months. JLR sales for the quarter also took a hit due to supply chain disruptions.

Analysts see continued pressure on Tata Motors sales in October. Tata Motors would continue to see a drop in its monthly sales volume in October, according to analysts at Anand Rathi. This is attributed to the high base in the previous year and the timing difference for stock build-up in the festive season.

Price Action: Tata Motors’ share price was down 0.29% to trade at ₹837.80 on Thursday morning.

Read Next: What’s Going On With RVNL’s Share Price Today?

Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.